Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 14, 2018 - Issue 2
Submit an article Journal homepage
269
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections

M. GalluzzoDepartment of Dermatology, University of Rome ‘Tor Vergata,’ Rome, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3424-5175View further author information
ORCID Icon,
S. D’AdamioDepartment of Dermatology, University of Rome ‘Tor Vergata,’ Rome, ItalyView further author information
,
L. BianchiDepartment of Dermatology, University of Rome ‘Tor Vergata,’ Rome, ItalyView further author information
&
M. TalamontiDepartment of Dermatology, University of Rome ‘Tor Vergata,’ Rome, ItalyView further author information
Pages 197-206 | Received 10 Sep 2017, Accepted 19 Dec 2017, Published online: 25 Dec 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gianluca Dell’Orso, Maura Faraci, Stefano Giardino, Marcello Mariani, Alessio Mesini & Elio Castagnola. (2021) Successful dalbavancin use in preventing reactivation of Staphylococcus aureus liver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation. Journal of Chemotherapy 33:7, pages 517-518.
Read now
Adriana Barreto-Santamaría, Manuel E. Patarroyo & Hernando Curtidor. (2019) Designing and optimizing new antimicrobial peptides: all targets are not the same. Critical Reviews in Clinical Laboratory Sciences 56:6, pages 351-373.
Read now

Articles from other publishers (7)

Milagros Suárez, Antonio Pérez-Landeiro, Ana Sanjurjo, Olalla Lima, Adrián Sousa, Ana López, Lucía Martínez-Lamas, Xurxo Cabrera, Martín Rubianes & María Teresa Pérez-Rodríguez. (2024) Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis. International Journal of Infectious Diseases 138, pages 41-45.
Crossref
Sudip Mukherjee, Rajib Dey, Yash Acharya & Jayanta Haldar. 2023. Antibiotics - Therapeutic Spectrum and Limitations. Antibiotics - Therapeutic Spectrum and Limitations 203 232 .
Maria Mazzitelli, Milo Gatti, Vincenzo Scaglione, Daniele Mengato, Marco Trevenzoli, Andrea Sattin, Federico Pea & Anna Maria Cattelan. (2022) Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience. Antibiotics 11:10, pages 1377.
Crossref
A. M. Morozov, A. N. Sergeev, E. M. Askerov, S. V. Zhukov, N. S. Novikova, M. A. Belyak & E. A. Sobol. (2021) Modern approach to antibacterial therapy in the practice of a surgeon. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 11:2, pages 79-86.
Crossref
Difeng Zhu, Li Ping, Yawen Hong, Jiale Shen, Qinjie Weng & Qiaojun He. (2020) Simultaneous Quantification and Pharmacokinetic Study of Five Homologs of Dalbavancin in Rat Plasma Using UHPLC-MS/MS. Molecules 25:18, pages 4100.
Crossref
Alberto CoronaAndrea AgarossiAlice VeroneseDario Cattaneo & Antonio D'Avolio. (2020) Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. Therapeutic Drug Monitoring 42:2, pages 165-168.
Crossref
Timothy J. Carrothers, Jason T. Chittenden & Ian Critchley. (2019) Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis. Clinical Pharmacology in Drug Development 9:1, pages 21-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.